LakeShore Biopharma Co. L... (LSB)
NASDAQ: LSB
· Real-Time Price · USD
0.76
-0.03 (-3.80%)
At close: Aug 15, 2025, 12:51 PM
-3.80% (1D)
Bid | 0.76 |
Market Cap | 31.33M |
Revenue (ttm) | 577.33M |
Net Income (ttm) | -436.09M |
EPS (ttm) | -0.73 |
PE Ratio (ttm) | -1.04 |
Forward PE | 0.5 |
Analyst | n/a |
Ask | 0.77 |
Volume | 5,017 |
Avg. Volume (20D) | 306,391 |
Open | 0.77 |
Previous Close | 0.79 |
Day's Range | 0.74 - 0.77 |
52-Week Range | 0.59 - 8.60 |
Beta | 0.57 |
1 month ago
+40.74%
LakeShore Biopharma shares are trading higher afte...
Unlock content with
Pro Subscription
10 months ago
+21.15%
LakeShore Biopharma shares are trading higher after the company announced preliminary H1 2025 financial results and guidance.

2 weeks ago · businesswire.com
LSB Industries, Inc. Reports Operating Results for the 2025 Second QuarterOKLAHOMA CITY--(BUSINESS WIRE)--LSB Industries, Inc. (NYSE: LXU) (“LSB,” “we,” “us,” “our,” or the “Company”) today announced results for the second quarter ended June 30, 2025. Second Quarter 2025 Re...